Is BioRegenx Inc halal to invest in?

According to Musaffa's Shariah screening methodology, BioRegenx Inc (BRGX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is BioRegenx Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioRegenx Inc using these criteria to determine its compliance status.

Can Muslims buy shares of BioRegenx Inc?

Muslim investors may consider investing in BioRegenx Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is BioRegenx Inc classified as NOT COVERED?

Musaffa determines the Shariah status of BioRegenx Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for BioRegenx Inc updated?

The Shariah compliance status of BioRegenx Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like BioRegenx Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of BioRegenx Inc?

You can check the latest Shariah compliance status of BioRegenx Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BioRegenx Inc. Stock Analysis BRGX

United States Consumer Staples Nano Cap

BioRegenx, Inc. develops a social media content management platform. The company is headquartered in Chattanooga, Tennessee and currently employs 6 full-time employees. The company went IPO on 2000-11-06. The Company’s subsidiaries include DocSun BioMedical Holdings, Inc. (DocSun), Microvascular Health Solutions, LLC (MVHS), MyBodyRx, LLC (MyBodyRx), NuLife Sciences, Inc. (NuLife) and Findit Ai Connect, Inc. (Findit Ai). DocSun combines three technologies in the DocSun Artificial Intelligence (AI) Engine. The DocSun AI Engine integrates advanced ballistocardiography, which can detect an individual's heartbeat without touch, and photoplethysmography, a method that uses light to track the flow of blood. MVHS specializes in research, product development, sales, and education, notably producing the patented Endocalyx Pro dietary supplement. MVHS also manufactures and distributes the patented GlycoCheck software and Class 1 medical devices. DocSun is also developing an app for NuLife, TruScan.Ai mobile app/Website.

Key Statistics of BioRegenx Inc (BRGX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.01$0.01

Today's Open

$0.01

Volume

101.00

P/E Ratio (TTM)

52 Week Range

$0.01$0.03

Market Cap

8.72M

Avg. Volume

22.60K

Dividend Yield

Financial Metrics & Statements of BioRegenx Inc (BRGX)

FAQ's for BioRegenx Inc (BRGX)

According to Musaffa’s Shariah screening methodology, BioRegenx Inc (BRGX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.